Patent ID: 8771745
Filing Date: 2014-07-08
Classification: A61K,A61L,A61P

Abstract:
1. A method of treating glaucoma, the method comprising anterior sub-tenon administration to a patient with glaucoma of a 50-μl pharmaceutical composition consisting of: (a) a plurality of microspheres made from a PLGA and/or PLA; (b) 1242 micrograms of latanoprost contained by the microspheres, and; (c) 50 μl of a high viscosity hyaluronic acid, the high viscosity hyaluronic acid corresponding to a gel formed of 18 mg of a cross-linked hyaluronic acid in 1 ml of phosphate buffer at pH 7.2, the cross-linked hyaluronic acid having an average molecular weight of about 2 million Daltons, thereby treating the glaucoma.